14-day Premium Trial Subscription Try For FreeTry Free
$11.76
+0.120 (+1.03%)
At Close: May 07, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $0.0060 $169.56 Tuesday, 7th May 2024 DVAX stock ended at $11.76. This is 1.03% more than the trading day before Monday, 6th May 2024. During the day the stock fluctuated 2.41% from a day low at $11.60 to a day high of $11.88.
90 days $113.65 $133.77
52 weeks $171.20 $133.77

Historical Dynavax Technologies Corporation prices

Date Open High Low Close Volume
Feb 28, 2022 $12.38 $12.70 $12.08 $12.26 3 278 300
Feb 25, 2022 $12.40 $12.49 $12.02 $12.48 1 111 900
Feb 24, 2022 $11.01 $12.48 $10.90 $12.44 2 437 100
Feb 23, 2022 $12.42 $12.44 $11.70 $11.71 1 661 000
Feb 22, 2022 $12.28 $12.67 $12.04 $12.27 1 462 200
Feb 18, 2022 $12.57 $12.88 $12.09 $12.34 1 236 500
Feb 17, 2022 $13.02 $13.08 $12.25 $12.45 1 490 900
Feb 16, 2022 $13.12 $13.25 $12.89 $13.04 845 600
Feb 15, 2022 $12.78 $13.44 $12.75 $13.32 1 251 500
Feb 14, 2022 $12.79 $12.94 $12.41 $12.51 1 058 000
Feb 11, 2022 $12.73 $13.50 $12.62 $12.90 2 301 200
Feb 10, 2022 $12.81 $13.56 $12.51 $12.74 1 946 200
Feb 09, 2022 $12.78 $13.11 $12.73 $13.08 1 464 200
Feb 08, 2022 $12.62 $12.69 $12.11 $12.62 1 244 300
Feb 07, 2022 $12.61 $12.95 $12.59 $12.75 1 056 100
Feb 04, 2022 $12.37 $12.90 $12.30 $12.62 1 343 000
Feb 03, 2022 $12.15 $12.62 $12.15 $12.37 1 728 100
Feb 02, 2022 $12.59 $12.72 $12.22 $12.41 1 497 300
Feb 01, 2022 $13.10 $13.13 $12.51 $12.65 1 581 800
Jan 31, 2022 $12.65 $13.02 $12.44 $12.97 1 683 900
Jan 28, 2022 $11.80 $12.62 $11.62 $12.60 1 583 300
Jan 27, 2022 $12.43 $12.64 $11.81 $11.85 1 712 900
Jan 26, 2022 $12.79 $13.33 $12.21 $12.35 1 939 000
Jan 25, 2022 $12.49 $12.77 $11.90 $12.60 2 014 300
Jan 24, 2022 $12.50 $12.67 $11.12 $12.60 3 939 500
Click to get the best stock tips daily for free!

About Dynavax Technologies Corporation

Dynavax Technologies Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufactures and sells CpG 1018, the adjuvant used in HEPLISAV-B. Dynavax Technologies Corporation has a coll... DVAX Profile

Golden Star

Ticker Date Change Price
BBCA May 03 1.26% $65.44
ADTH May 03 5.56% $3.24
ISTB May 03 0.0425% $47.11
WMT May 03 1.34% $59.82
UNP May 03 0.84% $240.36
INGR May 03 1.75% $114.56
ASH May 03 2.26% $95.85
WU May 03 0.449% $13.37
INVH May 03 1.72% $34.39
INTU May 03 1.89% $629.27
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT